The ALG1 gene helps cells add sugar chains to newly made proteins, a basic step that lets many proteins fold properly and do their jobs. The protein made by this gene helps your cells build these sugar tags, which support brain development, muscle tone, growth, and organ function. If both copies carry a pathogenic variant and the gene does not work well, a person can have ALG1-CDG, a genetic condition that may cause developmental delay, low muscle tone, feeding problems, seizures, and eye or liver problems.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or regulate processes throughout the body. Some genes provide the instructions for producing proteins, which are the parts of cells that do much of the work. Other genes mainly guide when certain processes happen, where they happen, and how active they are. Taken together, genes affect how your body develops and works, and they can shape how you respond to food, stress, or medications. For a more detailed look at this topic, you can learn more in the LearnHub.
Overview
ALG1Gene function
What if the gene works
The ALG1 gene helps cells build sugar chains that are attached to many proteins. These sugar tags help proteins fold properly and work throughout the body.
Risk
What if the gene does not work
Variants in the ALG1 gene can cause a rare glycosylation condition with developmental delay, low muscle tone, seizures, and sometimes vision, liver, or clotting problems. Effects range from milder to more severe, depending on how much protein function remains.
Treatment
What does that mean for your treatment
No ALG1-specific treatment or drug-choice approach is currently established in clinical guidelines; care is symptom-based and supportive. ALG1-related disease is being studied within the broader congenital disorders of glycosylation field, but targeted therapies remain investigational.
Conditions associated with ALG1
Gene function
What if the gene works
Many proteins need small sugar chains added before they can fold, travel, and work as expected. The ALG1 gene helps with an early step in this process inside the endoplasmic reticulum, a protein-processing area of the cell. This is a key part of how the ALG1 gene helps add sugars to proteins so they can mature in an orderly way.
The ALG1 gene adds an early mannose sugar to a growing sugar chain attached to a lipid carrier in the endoplasmic reticulum. This helps build the standard sugar tag many newly made proteins need.
Once that sugar tag is built correctly, many proteins can fold into a more stable working shape. This supports the cell’s normal quality control steps before proteins move on.
Proper sugar tagging helps cells sort and send proteins to the cell surface, outside the cell, or to internal compartments. This supports steady communication, signaling, and routine maintenance across many tissues.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants have no noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many variants in the ALG1 gene weaken the enzyme that helps cells build a sugar chain used in glycosylation (adding sugars to proteins). How the ALG1 gene variants affect protein function depends on the change: some small DNA changes make the protein unstable or less active, while more severe variants can sharply reduce or stop enzyme activity. This functional range can influence how much glycosylation remains and, in ALG1-CDG, may shape how early and how strongly features appear.
How variants are linked to conditions
Pathogenic variants in both copies of the ALG1 gene cause ALG1-CDG, a rare inherited condition in the congenital disorders of glycosylation group. In practical terms, ALG1 gene variants linked to conditions are most strongly tied to developmental delay, low muscle tone, seizures, feeding problems, and sometimes liver, eye, or blood clotting issues. When testing finds disease-causing variants in both copies, that result can confirm the diagnosis.
A variant is not necessarily a diagnosis
Genetic variants are a usual feature of human biology and are widely found across the general population. Most do not have a direct effect on health and instead reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a certain diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well understood variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For ALG1, risk is mainly shaped by inheritance rather than lifestyle. A child is affected when they inherit harmful ALG1 changes from both biological parents, so family history and whether both parents are carriers are the main factors that change risk.
Inheritance of ALG1 variants
ALG1-related conditions are inherited in an autosomal recessive pattern. This means a child usually needs to inherit two altered copies of the ALG1 gene, one from each parent, to be affected. Parents who each carry one ALG1 variant are usually unaffected carriers, and with each pregnancy there is a 25% chance the child will inherit both variants, a 50% chance the child will be a carrier, and a 25% chance the child will inherit neither altered copy. In practical terms, how ALG1 variants are inherited usually involves both sides of the family, even when no one else has symptoms.
What does my ALG1 result mean for my family?
ALG1-related conditions are usually passed down in a recessive pattern, so close relatives may also be carriers even if they do not have symptoms. Brothers and sisters of an affected child may also be affected or be carriers. Other family members, such as parents, adult siblings, and relatives planning children, may also want to learn whether they carry the same ALG1 change.
Genetic information
Genetic testing
How you find out about variants
Variants in the ALG1 gene are usually found with ALG1 genetic testing, often as part of a broader panel or exome test using a blood sample or saliva. A lab reads the gene's DNA code and compares it with the usual sequence to look for changes that may help explain symptoms.
When should I consider getting a genetic test?
Consider ALG1 testing if a baby or child has signs of a rare inherited condition, such as major developmental delay, low muscle tone, seizures, feeding problems, or unexplained liver or bleeding issues. It can also help when there is a known ALG1 variant or an affected child in the family.
A genetic result is only one part of your health story
Genetic results can offer valuable insight, but how much they reveal depends on the condition and the type of variant involved. Many factors, including lifestyle, environment, age, and medical history, influence how the body works over time. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Small differences in genes can change how a drug is broken down, how it moves through the body, or how strongly your body reacts to it. This helps explain why the same medication may work well for one person, work less well for another, or cause more side effects in someone else. These differences are common and are one part of the bigger picture alongside age, overall health, and other medicines.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes can affect a person’s response to medicines. It studies the relationship between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medications, genes help shape how strongly a drug works or how the body handles it. This information can support treatment decisions that are more informed and more personalized. You can read more about this topic in the LearnHub if you want to explore it further.
Drugs influenced by the ALG1 gene
When should I seek medical advice?
There is not yet a broadly confirmed link between this gene and how people respond to medicines. For now, questions about symptoms, treatment changes, or possible side effects are best discussed with your doctor.